FAAH inhibitors and CB2 agonists (University of Lille Nord de France/Lille Catholic University)

N/A

Report date: 2025/03/20 16:00:19
NME

Base Information

Drug NameFAAH inhibitors and CB2 agonists (University of Lille Nord de France/Lille Catholic University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnandamide amidohydrolase inhibitorsCannabinoid CB2 receptor agonists
TargetsAnandamide amidohydrolaseCannabinoid CB2 receptor
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Lille Nord De France
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Lille Nord De FranceLille Catholic University
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A